| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9561204 | ARBOR PHARMS LLC | Effervescent compositions containing N-acetylcysteine |
May, 2032
(8 years from now) | |
| US8747894 | ARBOR PHARMS LLC | Effervescent compositions containing N-acetylcysteine |
May, 2032
(8 years from now) | |
| US9427421 | ARBOR PHARMS LLC | Effervescent compositions containing N-acetylcysteine |
May, 2032
(8 years from now) | |
Cetylev is owned by Arbor Pharms Llc.
Cetylev contains Acetylcysteine.
Cetylev has a total of 3 drug patents out of which 0 drug patents have expired.
Cetylev was authorised for market use on 29 January, 2016.
Cetylev is available in tablet, effervescent;oral dosage forms.
Cetylev can be used as method of treating acetaminophen overdose with acetylcysteine solutions.
The generics of Cetylev are possible to be released after 08 May, 2032.
Drugs and Companies using ACETYLCYSTEINE ingredient
Market Authorisation Date: 29 January, 2016
Treatment: Method of treating acetaminophen overdose with acetylcysteine solutions
Dosage: TABLET, EFFERVESCENT;ORAL
CETYLEV family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic